Early versus Late Pre-emptive Allogeneic Hematopoietic Cell Transplantation (p-alloHCT) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Many patients with relapsed or refractory acute myeloid leukemia (AML) do not receive allogeneic hematopoietic cell transplant (alloHCT) because they are unable to achieve a complete remission (CR) after reinduction chemotherapy. Starting in January 2003, we prospectively assigned patients with AML...

詳細記述

保存先:
書誌詳細
出版年:Biol Blood Marrow Transplant
主要な著者: Chen, George L., Liu, Hong, Zhang, Yali, Thomas, Julie, Ross, Maureen, Wang, Eunice S., Block, AnneMarie W., Sait, Sheila, Deeb, George, Wallace, Paul, Wetzler, Meir, Hahn, Theresa, McCarthy, Philip L.
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292802/
https://ncbi.nlm.nih.gov/pubmed/24867777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.05.013
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料